Loading...
XJPX
3079
Market cap62mUSD
Jul 10, Last price  
963.00JPY
1D
-0.21%
1Q
-6.50%
Jan 2017
-29.76%
IPO
366.91%
Name

DVx Inc

Chart & Performance

D1W1MN
XJPX:3079 chart
P/E
44.87
P/S
0.18
EPS
21.46
Div Yield, %
5.18%
Shrs. gr., 5y
0.34%
Rev. gr., 5y
6.43%
Revenues
55.99b
+11.26%
9,911,000,00011,740,000,00013,080,000,00015,793,556,00018,000,829,00020,487,399,00022,872,235,00026,420,963,00028,647,863,00031,372,131,00035,266,794,00038,275,742,00040,380,089,00044,653,770,00041,007,008,00045,496,274,00047,483,757,00045,851,074,00050,321,644,00055,988,774,000
Net income
225m
-45.04%
193,000,000236,000,000277,000,000324,845,000357,145,000476,038,000682,742,000788,549,000919,948,0001,289,737,0001,025,999,000856,128,000974,181,000792,028,000572,367,000863,016,000936,184,000172,913,000410,119,000225,381,000
CFO
-1.27b
L
275,000,000349,252,000337,571,000501,606,000146,382,000457,611,0001,281,412,000283,738,000515,836,0001,311,925,0001,152,166,0001,205,839,000290,272,0001,045,392,0001,743,161,0001,687,188,0001,484,945,000-422,567,000725,543,000-1,273,570,000
Dividend
Mar 30, 202650 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DVx Inc., a Japanese company founded in 1986 and headquartered in Tokyo, specializes in the import and export of medical devices and their accompanying peripheral equipment within Japan. The firm offers a diverse portfolio of products, including those addressing arrhythmia, such as cardiac pacemakers, implantable cardioverter defibrillators, and various electrode and ablation catheters. It also provides ischemia-related solutions, notably excimer laser systems. A significant portion of its offerings includes specialized equipment designed to minimize scatter radiation exposure for medical personnel during fluoroscopy procedures, featuring products like RADPAD (for general protection), RADNEK (for thyroid protection), and RADCAP (for head protection). Additionally, DVx supplies resolution/resolution SD devices and wonder belt products. Beyond sales and distribution, the company is actively involved in the full spectrum of medical device operations, encompassing research, development, manufacturing, repair, and leasing. DVx Inc. further provides general consulting and services related to medical and medical device industries, alongside engaging in medical publishing and market research activities.
IPO date
Apr 25, 2007
Employees
319
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT